All Ro healthcare professionals are licensed in the United States, and the company claims to perform a background check and a license verification process for each professional
Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity since the US Food & Drug Administration first approved semaglutide (brand name Ozempic/Wegovy) for weight loss in 2021
But, these same actions can cause some common side effects like upset stomach, nausea, vomiting, diarrhea, abdominal pain, and constipation
Other attributes Water, residual solvents, counter-ions, bioburden, endotoxin, and sterility each require method-specific evidence when relevant to the use case
Social media discussions about side effects can create unnecessary anxiety
Treatment of Nonalcoholic Fatty Liver Disease: Role of AMPK